title: Post-transplant headache: benefit from riboflavin.
abstract: Post-transplant headache is a recognized complication of organ transplantation. Its treatment can sometimes be problematic given the status of the patient and the risk of drug interference. Six organ-transplanted patients (5 liver and 1 heart) experiencing post-transplant headache were successfully treated with riboflavin 200 mg daily. The drug proved safe and well tolerated and its properties are unlikely to produce clinically relevant drug interactions in the transplant recipient. Awaiting specific trials, riboflavin is proposed as an option for the preventive treatment of post-transplant headache.
authors.affiliation: Neurology Unit, S. Orsola-Malpighi University Hospital, Bologna, Italy. str.andrea@aosp.bo.it
authors.forename: Andrea
authors.initials: A
authors.lastname: Stracciari
authors.forename: Roberto
authors.initials: R
authors.lastname: D'Alessandro
authors.forename: Elisa
authors.initials: E
authors.lastname: Baldin
authors.forename: Maria
authors.initials: M
authors.lastname: Guarino
mesh_terms: D000328:Adult; D005260:Female; D006261:Headache / Q000209:etiology / Q000517:prevention & control*; D006801:Humans; D008297:Male; D008875:Middle Aged; D016377:Organ Transplantation / Q000009:adverse effects*; D011183:Postoperative Complications / Q000209:etiology / Q000517:prevention & control*; D012256:Riboflavin / Q000627:therapeutic use*; D014803:Vitamin B Complex / Q000627:therapeutic use*
chemical_list: D014803:Vitamin B Complex; D012256:Riboflavin